Breaking News

AstraZeneca Invests in Nucleus RadioPharma

Nucleus working to expand development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Nucleus RadioPharma, an integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, announced the closing of a Series A extension round with new investor AstraZeneca. AstraZeneca joins existing investors from GE Healthcare, Mayo Clinic, Eclipse Ventures, Fox Chase Cancer Center, Echo Global Granger Management Mercy Health, and the University of Missouri as Nucleus expands development, supply, and commercial manufacturing capabilities to make targeted radiothera...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters